Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000919574-03-000142
Filing Date
2003-01-31
Accepted
2003-01-31 16:13:33
Documents
1

Document Format Files

Seq Description Document Type Size
1 d381247_13g-a.txt SC 13G/A 14932
  Complete submission text file 0000919574-03-000142.txt   16905
Mailing Address CURRAN PARTNERS LP 230 PARK AVENUE NEW YORK NY 1010017
Business Address CURRAN PARTNERS LP 230 PARK AVENUE NEW YORK NY 10017 2128082400
CURRAN JOHN P (Filed by) CIK: 0000026256 (see all company filings)

 

Mailing Address 425 WOODSMILL RD ST LOUIS MO 63017
Business Address 425 WOODSMILL RD ST LOUIS MO 63017 3145799899
SHEFFIELD PHARMACEUTICALS INC (Subject) CIK: 0000894158 (see all company filings)

EIN.: 133808303 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-43720 | Film No.: 03534812
SIC: 2834 Pharmaceutical Preparations